ReferenceID 5832
Anti-inflammatory effect evaluation of naringenin and its incorporation into a chitosan-based film for transdermal delivery
Int J Pharm
Naringenin is a bioflavonoid mainly found in citrus fruits. It presents many pharmacological benefits, including a remarkable anti-inflammatory activity, but its oral bioavailability is poor. To overcome this drawback, t
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 5832
- Evidence Id
- 22422
- Core Evidence Id
- 22422
- Source Reference Id
- 4922
- Herb2 Reference Id
- HBREF005719
- Subject Paper Key
- HBIN036367_36167188
- Pubmed Id
- 36167188
- Doi
- 10.1016/j.ijpharm.2022.122231
- Paper Title
- Anti-inflammatory effect evaluation of naringenin and its incorporation into a chitosan-based film for transdermal delivery
- Paper Abstract
- Naringenin is a bioflavonoid mainly found in citrus fruits. It presents many pharmacological benefits, including a remarkable anti-inflammatory activity, but its oral bioavailability is poor. To overcome this drawback, this work proposes a transdermal administration of such bioflavonoid, considering its use in the chronic treatment of inflammatory conditions. For this, it aims to develop a chitosan-based film that guarantees a consistent transdermal delivery of the drug. First, naringenin's in vitro anti-inflammatory effect on T-cell proliferation was evaluated, followed by research on the modulation of gene expression for inflammatory factors in peripheral blood mononuclear cells. Chitosan films were then prepared and characterized. Afterward, naringenin release profile from a selected film was determined as well as the drug permeation across porcine skin provided by the film. Naringenin induced the expression of the anti-inflammatory factors IL-10 and TGF-β1 while inhibiting the expression of the pro-inflammatory cytokine IL-1β and limiting T-cell proliferation. The chitosan film was successfully developed, and the drug was progressively released to the physiological media following both first order and Korsmeyer-Peppas kinetics. When topically applied, the chitosan film guaranteed a constant and continuous diffusion of naringenin across the skin over 72 h. Indeed, the permeation flux of naringenin was 0.30 ± 0.01 µg/cm 2 /h, which means a concentration in the receptor solution 14-fold (p < 0.05) higher than that provided by the drug solution. Thus, the chitosan film represents a promising transdermal alternative for the long-term treatment of inflammatory conditions using naringenin.
- Journal
- Int J Pharm
- Publish Year
- 2022
- Experiment Subject
- Experiment Type
- Others
- Phenotype Related
- Paper Title Cn
- Paper Title En
- Anti-inflammatory effect evaluation of naringenin and its incorporation into a chitosan-based film for transdermal delivery
- Bilingual Status
- semi_complete